Related by context. All words. (Click for frequent words.) 72 platelet aggregation 67 platelet activation 66 VerifyNow 65 endothelial function 65 Akt activation 65 paricalcitol 64 platelet inhibition 64 myocardial reperfusion 64 platelet reactivity 63 antiplatelet therapies 63 albuminuria 63 plasma renin activity 63 intima media thickness 63 carotid IMT 63 p# activation 62 peptide BNP 62 tissue oxygenation 62 Lp PLA 2 62 ERK1 2 62 Lp PLA2 62 neuronal function 62 hsCRP 62 exhaled nitric oxide 62 cardiac repolarization 62 chemosensitivity 62 antitumor efficacy 62 renal fibrosis 62 thrombotic complications 62 ventricular remodeling 62 intestinal mucosal 62 prognostic significance 62 infarct size 61 receptor subtypes 61 troponins 61 vascular reactivity 61 VKORC1 61 IL 1ß 61 β blockers 61 vWF 61 eNOS 61 TPMT 61 serum calcium 61 cardiac troponin 61 hypotensive 61 VEGF induced 61 fulvestrant 61 TNF α 61 vasodilatation 61 antitumor effect 61 serum cortisol 61 cystatin C 61 antithrombotic 61 PECAM 1 61 selenium supplementation 61 liver histology 61 clusterin 61 insulin sensitizing 61 CYP#C# genotype 61 mitochondrial function 61 neointimal hyperplasia 60 ApoA1 60 adrenal function 60 lactate dehydrogenase LDH 60 atherosclerotic lesions 60 proteoglycan 60 lipid levels 60 myocardial function 60 histone acetylation 60 serum cholesterol 60 thyroid stimulating hormone 60 renal function 60 Xanafide 60 plasma pharmacokinetics 60 thyroglobulin 60 serum concentrations 60 LTB4 60 aldosterone 60 colorectal adenoma 60 metabolic parameters 60 cardiac biomarkers 60 IFN beta 60 VEGF expression 60 endothelial activation 60 cerebral perfusion 60 lung metastasis 60 BH4 60 neurocognitive function 60 myocardial contractility 60 p# MAPK 60 plasma lipids 60 PGE2 60 PPAR γ 60 hemodynamics 60 troponin T 60 hemodynamic variables 60 cTnI 60 myeloperoxidase 60 graft patency 60 serum calcium levels 60 myocardial necrosis 60 vascular permeability 60 alteplase 60 glomerular filtration 60 hypoperfusion 60 ACh 60 Corus CAD 60 galectin 3 59 fibrinolysis 59 autoregulation 59 hepatic fibrosis 59 EGFR signaling 59 serum uric acid 59 surrogate marker 59 myocardial viability 59 hypericin 59 selective inhibition 59 aldosterone hormone 59 endoglin 59 PSADT 59 endothelium dependent 59 trastuzumab Herceptin ® 59 atherogenesis 59 cardiovascular morbidity 59 NGAL 59 HPA axis 59 coagulation parameters 59 fatty acid oxidation 59 ADAMTS# 59 antioxidant supplementation 59 bronchodilation 59 inhibit platelet aggregation 59 eosinophil count 59 ABCB1 59 hypertonic saline 59 vimentin 59 microglial activation 59 microvascular complications 59 cardioprotective effects 59 adiponectin levels 59 prostate cancer CaP 59 neurotrophic 59 artery stenosis 59 pressure natriuresis 59 glycogen metabolism 59 myocardial 59 immunohistochemical 59 LRP5 59 fibrotic disease 59 TNFalpha 59 serum biomarkers 59 serum lipid 59 intestinal permeability 59 primidone 59 tHcy 59 glycemia 59 thyrotropin 59 lung fibrosis 59 N acetylcysteine 59 coagulation abnormalities 59 GRK2 59 pharmacokinetic PK profile 59 pro angiogenic 59 pulsatility 59 cardiac troponin T 59 baroreceptors 59 ginkgo extract 58 pharmacodynamic effects 58 neuroinflammatory 58 serum phosphate 58 atherosclerotic disease 58 anti fibrotic 58 breast cancer metastasis 58 thyroxine 58 prognostic marker 58 biologic plausibility 58 hypervascular tumors 58 factor Xa 58 renoprotective 58 intracoronary 58 glucose homeostasis 58 AT1R 58 cediranib 58 EP1 receptor 58 prostaglandin synthesis 58 mRNA expression 58 plasma creatinine 58 natriuretic peptide 58 activated partial thromboplastin 58 bezafibrate 58 colorectal liver metastases 58 HER3 58 Cotinine 58 olmesartan 58 isoproterenol 58 candesartan cilexetil 58 nicardipine 58 oncomodulin 58 bone resorption 58 inotropic 58 thromboxane A2 58 arterial calcification 58 serum phosphorous 58 airway hyperresponsiveness 58 serotonin synthesis 58 procalcitonin 58 biomarker 58 mucociliary clearance 58 vessel dilation 58 Natalizumab 58 cardiac toxicity 58 thrombus formation 58 indomethacin 58 mitochondrial toxicity 58 teriflunomide 58 IL6 58 effector function 58 cardioprotection 58 carcinoembryonic antigen 58 erythropoiesis 58 natriuresis 58 nephrotoxicity 58 postprandial glycemia 58 intensive lipid lowering 58 intraventricular 58 antiangiogenic therapy 58 prostanoid 58 TNFa 58 agonist induced 58 mecamylamine 58 P selectin 58 diagnostic modality 58 genetic polymorphisms 58 tyrosine phosphorylation 58 Lisofylline 58 cellular pathways 58 myocardial tissue 58 cTnT 58 vecuronium 58 recombinant tissue plasminogen 58 E selectin 58 FISH fluorescence 58 glycosylated hemoglobin HbA1c 58 glomerular filtration rate 58 beta blocker therapy 58 CTAP# Capsules 58 antiplatelet drugs 58 activate p# 58 gene amplification 58 lipid lowering therapies 58 β amyloid 58 P#Y# [002] 58 d dimer 58 cinacalcet 58 prothrombin 58 urate levels 58 vasodilation 58 carbohydrate metabolism 58 cathepsin K 58 stratifying patients 58 haemodynamic 58 inhaled nitric oxide 58 DNA methylation patterns 58 GPx 58 apolipoproteins 58 subclinical atherosclerosis 58 upper gastrointestinal bleeding 58 cardiac conduction 58 dopamine reuptake 58 imatinib resistance 58 rt PA 58 AST ALT 58 BACE1 58 CYP#C# [001] 58 hydralazine 58 isoenzyme 58 ApoB 57 dose atorvastatin 57 amyloid deposition 57 imatinib Gleevec 57 aP2 57 WT1 57 contractile function 57 cholesterol homeostasis 57 Vidaza azacitidine 57 protein excretion 57 VE cadherin 57 Bcl xL 57 KRAS mutation status 57 CTGF 57 analgesic efficacy 57 biodistribution 57 triiodothyronine 57 glycated hemoglobin levels 57 synthase TS 57 prostate cancer PCa 57 catheter angiography 57 electrophysiologic 57 cardiac contractility 57 ON #.Na 57 autophagic 57 irbesartan 57 ventricular tachyarrhythmia 57 hypothalamic pituitary adrenal axis 57 hemolysis 57 CYP #A# 57 COX2 57 muscarinic receptors 57 intact parathyroid hormone 57 Randomized clinical trials 57 left ventricular systolic 57 Clusterin 57 vasopressor 57 vascular inflammation 57 serum phosphate levels 57 Galectin 3 57 rtPA 57 estrogen receptor alpha 57 PTH secretion 57 neurofibromin 57 creatinine levels 57 myocardial ischemia 57 hs CRP 57 enzymatic activity 57 liver fibrosis 57 coronary stenoses 57 antithrombotic therapy 57 PTHrP 57 postoperative AF 57 QT intervals 57 glomerular 57 cerebral vasospasm 57 platelet inhibitor 57 fibrin deposition 57 transthyretin 57 estrogen metabolites 57 skin sterol 57 Th1 cells 57 Vidofludimus 57 serum glucose 57 pulmonary arterial 57 lipoprotein levels 57 immunohistochemical staining 57 RBP4 57 biochemical marker 57 haematopoietic 57 hyperphenylalaninemia HPA due 57 ERK signaling 57 gefitinib Iressa 57 pleural fluid 57 lipoprotein 57 thrombolytic agents 57 Aldosterone 57 bone metabolism 57 breast cancer subtypes 57 erythropoietic 57 anticancer activity 57 perfusion MRI 57 IGFBP 3 57 prolongs survival 57 ximelagatran 57 iNOS 57 HMG CoA reductase 57 VAPRISOL 57 hyperalgesia 57 hemodilution 57 inflammatory biomarkers 57 plasma fibrinogen 57 antiangiogenic 57 hematological parameters 57 platelet clumping 57 c reactive protein 57 chemoresistance 57 mTOR mammalian target 57 blood glucose concentrations 57 airway inflammation 57 TGF ß 57 pharmacodynamic PD 57 antihypertensive therapy 57 diabetic kidney 57 elastase 57 histone deacetylases 57 endotoxemia 57 NT proBNP 57 flow mediated dilation 57 Homocysteine 57 ImmuKnow 57 natriuretic peptides 57 cardio protective 57 myocardial perfusion 57 coagulation cascade 57 MAO B 57 Elevated serum 57 GAMMAGARD 57 neuroregenerative 57 cells MSCs 57 hepatic glucose production 57 antiandrogens 57 postoperative mortality 57 MMP inhibitors 57 imatinib therapy 57 HIF 1a 57 hemoglobin Hb 57 GP IIb IIIa inhibitors 57 fibrogenesis 57 SSc 57 thromboembolism 57 riociguat 57 inhibitory effects 57 mucosal healing 57 vasoconstrictor 57 PPARγ 57 hepatotoxicity 57 IL 1beta 57 pituitary hormones 57 growth hormone secretion 57 coadministration 57 QTc prolongation 57 IFN γ 57 calcineurin 57 tissue perfusion 57 LPS induced 57 surrogate endpoint 57 molecular biomarkers 57 fibrinolytic 57 osteopontin 57 coronary stenosis 57 glycosylated hemoglobin levels 57 albumin excretion rate 57 varespladib 57 osteolytic 57 left ventricular dysfunction 57 interleukin IL -6 57 PARP inhibition 57 neuronal differentiation 57 menadione 57 PlGF 57 vascular endothelial 57 MTHFR 57 metabolic acidosis 57 overt nephropathy 57 endothelial nitric oxide synthase 57 neurologic progression 57 leflunomide 57 plasma triglycerides 57 S#A# [002] 57 azacytidine 57 C Reactive Protein 57 gene polymorphisms 57 allopregnanolone 57 plasminogen 57 PITX2 57 CD# expression [002] 57 pharmacodynamic parameters 57 myocyte 57 small molecule activators 57 prostacyclin 57 CLA supplementation 57 osteoblast 57 KRAS mutation 57 salivary flow 57 Estradiol 57 postoperative pulmonary 57 antiplatelet 57 lymphangiogenesis 57 baroreflex 57 HER2 expression 57 mutational status 57 nitric oxide synthase 57 amiloride 57 Abeta# 57 ACTH 57 dose dependently 57 NF kappaB activation 57 leukocyte count 57 perfusion abnormalities 57 antiplatelet therapy 56 osteoclast formation 56 D dimer 56 OPCAB 56 immunological responses 56 leukotriene 56 NKG2D 56 cisplatin resistant 56 selective modulator 56 FVIII 56 colorectal tumor 56 anti coagulant therapy 56 DAPT 56 podocyte 56 metastatic malignant 56 CEACAM1 56 cytotoxicity 56 angiographically 56 clinically insignificant 56 analgesic effects 56 serum lipid levels 56 adrenocorticotropic hormone ACTH 56 remyelination 56 coronary endothelial 56 serum urate levels 56 steroidogenic 56 colonic mucosa 56 calcitriol 56 transgene expression 56 plasminogen activator inhibitor 56 dissolving clots 56 IFRD1 56 tumor hypoxia 56 pharmacologic approaches 56 Rasilez Tekturna 56 reperfusion injury 56 glucocorticoid 56 homocysteine concentrations 56 nattokinase 56 MSMB 56 OGG1 56 mixed hyperlipidemia 56 SERCA2a 56 clopidogrel Plavix 56 urinary excretion 56 hemoglobin A1c HbA1c 56 inhibiting COX 56 Tranexamic acid 56 intracerebral haemorrhage 56 QTc intervals 56 F FDG PET 56 cAMP signaling 56 ATACAND 56 protamine 56 lipid profiles 56 mutated K ras 56 aminotransferases 56 myocardial uptake 56 leukocyte 56 antiplatelet medication 56 clot formation 56 L arginine 56 cell adhesion molecule 56 ADAS Cog 56 pulmonary toxicity 56 HepG2 cells 56 receptor blockers 56 CK MB 56 Cystatin C 56 antibody mediated 56 Atacand 56 thrombotic events 56 cortisol concentrations 56 receptor inhibitor 56 axonal degeneration 56 anti CD3 56 follicle stimulating hormone FSH 56 endometrial hyperplasia 56 arterial inflammation 56 c MYC 56 hypertensives 56 synaptic transmission 56 QTc interval 56 anticoagulation 56 postprandial glucose 56 neurite outgrowth 56 secretory phospholipase A2 sPLA2 56 LDL oxidation 56 flavopiridol 56 microglial 56 Celecoxib 56 symptomatic VTE 56 diabetic gastroparesis 56 flecainide 56 nicotinamide 56 GLI1 56 angiogenesis inhibitor 56 cardiac autonomic 56 glucose concentrations 56 intracranial stenosis 56 alkaline phosphatase ALP 56 beta adrenergic 56 immune modulator 56 antiangiogenic agent 56 bronchoalveolar lavage 56 hepatic toxicity 56 Inosine 56 nicotinic acid 56 prognostic indicators 56 hedgehog signaling 56 inflammatory markers 56 NMP# protein 56 postmenopausal estrogen 56 thickness IMT 56 Bcr Abl 56 microcirculatory 56 Doxil ® 56 antiarrhythmic 56 deferiprone 56 Nitric oxide NO 56 fosbretabulin 56 monocyte chemoattractant protein 56 idraparinux 56 therapeutic regimens 56 neurohormonal activation 56 Symadex 56 troponin 56 rFVIIa 56 physiologic 56 TGF b 56 contrast induced nephropathy 56 depsipeptide 56 serum BDNF 56 simvastatin ezetimibe 56 prognostic indicator 56 L lysine 56 folate metabolism 56 GRP# 56 obstructive CAD 56 thrombi 56 bronchoalveolar lavage fluid 56 tryptase 56 membranous nephropathy 56 neurotransmitter GABA 56 lipid parameters 56 calcium antagonists 56 opioid analgesia 56 aspirin clopidogrel 56 prognostically 56 ovarian function 56 signaling cascades 56 NAGS deficiency 56 macrovascular 56 intestinal motility 56 ischemic myocardium 56 baroreceptor 56 IGF 1R 56 HIF 1α 56 bradykinin 56 oxidized LDL 56 glutamate signaling 56 peripheral blood mononuclear 56 carotid atherosclerosis 56 dobutamine 56 endothelial dysfunction 56 apolipoprotein B 56 aminotransferase ALT 56 perioperatively 56 MP4OX 56 thrombogenic 56 NYHA functional class 56 MMP2 56 immunomodulatory effects 56 immunomodulation 56 hsCRP levels 56 anti leukemic 56 hyperactivation 56 aPTT 56 induced sputum 56 Treg cell 56 PEDF 56 hormone angiotensin II 56 thromboembolic disease 56 prostate carcinoma 56 enzastaurin 56 fatty acid metabolism 56 lipid oxidation 56 liver metastasis 56 dietary carbohydrate 56 receptor activation 56 CYT# potent vascular disrupting 56 thalidomide Thalomid 56 adipogenic 56 oxysterols 56 NPD1 56 metabolite concentrations 56 pharmacodynamic profile 56 endoxifen 56 prognostic markers 56 intravascular hemolysis 56 endothelial nitric oxide 56 mTOR inhibitors 56 hepatic function 56 intraobserver 56 factor Xa inhibitor 56 EGFR tyrosine kinase inhibitors 56 anti androgen 56 lactate dehydrogenase 56 uric acid levels 56 FDG PET 56 pyridostigmine 56 malignant transformation 56 latanoprost 56 cytokine signaling 56 B type natriuretic 56 recurrent glioblastoma multiforme 56 plasma lipid 56 Teriflunomide 56 systolic function 56 Angiotensin II 56 C reactive protein 56 serum potassium 56 DFMO 56 distensibility 56 scintigraphic 56 Sjögren syndrome 56 chronic thromboembolic pulmonary 56 Anticalins ® 56 PNH patients 56 bleomycin 56 urothelial cancer 56 specific antigen PSA 56 eculizumab therapy 56 thymidylate synthase TS 56 ischemia induced 56 kinase inhibition 56 UGT#A# 56 erlotinib Tarceva 56 microcirculation 56 chromosomal mutations 56 TGF beta1 56 Pemetrexed 56 Prostate Specific Antigen PSA 56 macrophage infiltration 56 tumor necrosis 56 leukocyte recruitment 56 SPECT imaging 56 axon regeneration 56 gastric pH 55 ubiquinol 55 redox active 55 TGF β 55 neurodevelopmental outcome 55 arterial stiffness 55 revascularization procedures 55 ouabain 55 cangrelor 55 urine cytology 55 serum PSA 55 hemostatic efficacy 55 VEGF receptor 55 STRIDE PD 55 transthoracic 55 reticulocytes 55 thrombolytics 55 ABL1 55 inhibitory neurotransmitters 55 anticoagulant medication 55 serum albumin 55 radiosensitivity 55 preclinically 55 iloprost 55 CYP#D# 55 antiarrhythmic drugs 55 Prolactin 55 activin 55 HIF PH inhibitors 55 IL 1β 55 UCP2 55 proteolysis 55 Inhaled nitric oxide 55 hepatotoxic 55 vasomotor symptoms 55 mycophenolate mofetil 55 tegaserod 55 HuR 55 bronchial hyperresponsiveness 55 Cytoxan 55 Tyrima 55 carotid plaque 55 iPTH 55 isoprostane 55 symptomatic intracranial 55 intraocular pressure IOP 55 calcium homeostasis 55 bioavailable testosterone 55 HIV HCV coinfected 55 cyclooxygenase 2 55 RAS blockers 55 warfarin dosage 55 periprocedural 55 tracheal intubation 55 serum creatinine levels 55 STAT1 55 AT1 receptor 55 endothelium 55 RIP1 55 extracellular dopamine 55 TGF beta pathway 55 ^ sup #m 55 neuroprotective effects 55 radiotherapy RT 55 urodynamic 55 immuno modulatory 55 EGFr 55 Alzheimer disease pathology 55 antioxidant enzyme 55 NPM1 mutation 55 interleukins 55 albumin creatinine ratio 55 myo inositol 55 synaptic function 55 airway hydration 55 ventilatory 55 degranulation 55 infarcted myocardium 55 inducible nitric oxide synthase 55 ZOLINZA 55 biopsied tissue 55 chemopreventive agent 55 WNK1 55 Akt phosphorylation 55 bronchodilatory 55 adrenocorticotropic hormone 55 receptor subtype 55 decompensated heart failure 55 membrane permeability 55 sulindac 55 PSA nadir 55 HMG CoA reductase inhibitors 55 intestinal absorption 55 baroreceptor reflex 55 hypertensive patients 55 pharmacokinetic characteristics 55 ectopic expression 55 inhibit platelet function 55 serum triglycerides 55 upregulating 55 CDK inhibitor 55 busulfan 55 adrenocortical 55 adenosine diphosphate ADP 55 ischemic penumbra 55 TOP2A 55 salivary cortisol 55 bowel motility 55 ABCA1 55 RBP4 levels 55 ERK activation 55 mediated inhibition 55 podocytes 55 epithelial barrier 55 antiapoptotic 55 systemic hypotension 55 biologic pathways 55 β cell 55 atherosclerosis regression 55 serine proteases 55 Immunosuppressive drugs 55 arterial elasticity 55 immunostimulatory effects 55 PARP1 55 plasminogen activators 55 cerebral oxygenation 55 anti angiogenic drugs 55 apoB 55 ARB telmisartan 55 renal toxicity 55 tumorigenicity 55 apelin 55 neurohormone 55 antiproliferative effects 55 inotropic agents 55 galiximab 55 ULORIC 55 vessel constriction 55 surrogate markers 55 capillary density 55 Smad3 55 gastric mucosa 55 antidepressant efficacy 55 circulating lymphocytes 55 microRNA profiling 55 radioiodine therapy 55 rCBF 55 AGTR1 55 GLYX 55 differential gene expression 55 effector functions 55 vasodilators 55 deferasirox 55 acamprosate 55 postoperative morbidity 55 chemoprotective 55 secondary hyperparathyroidism 55 recombinant erythropoietin 55 thromboxane 55 serum sodium 55 genotoxicity 55 oxcarbazepine 55 HNSCC 55 cyclosporin 55 VerifyNow P#Y# Test 55 sFlt 1 55 RT qPCR 55 angiotensin II receptor 55 polyamines 55 PIK3CA 55 C1q 55 serum TSH 55 Sertoli cells 55 cytotoxic effects 55 allergic inflammation 55 5 Fluorouracil 55 nitrotyrosine 55 annexin 55 oral anticoagulation 55 EGF receptors 55 thiazide diuretic 55 antiplatelet agents 55 microRNA expression 55 indibulin 55 CCR3 55 proNGF 55 lipoprotein metabolism 55 oral anticoagulant therapy 55 fluvastatin 55 CLL cells 55 LVEF 55 Oligonol 55 pancreatic ducts 55 vasoconstriction 55 cardiac myocytes 55 soy isoflavone 55 Notch1 55 disease progression 55 glycolytic 55 genotoxic stress 55 dose clopidogrel 55 colorectal carcinoma 55 paclitaxel eluting stents 55 xenograft models 55 Endothelial dysfunction 55 coronary vessels 55 ischemic stroke 55 cholesterol biosynthesis 55 parathyroid 55 thromboembolic 55 pharmacologic 55 diastolic dysfunction 55 K ras mutations 55 fasting glucose levels 55 PTP 1B 55 pharmacodynamic 55 systemic inflammation 55 #F FDG PET 55 central corneal thickness 55 glial tumors 55 hypermethylation 55 lupus anticoagulant 55 serum leptin 55 fondaparinux 55 BYSTOLIC 55 mu opioid receptor antagonist 55 RQ PCR 55 IFN gamma 55 idarubicin 55 neurohormones 55 thiazide diuretics 55 EphB2 55 ptau 55 immunohistochemical analysis 55 adipocyte 55 impaired endothelial 55 Hydroxyurea 55 Ivabradine 55 NAbs 55 hematopoietic cell 55 autoantibody levels 55 Akt 55 hypercholesterolaemia 55 Valproic acid 55 adenomatous 55 hepatocellular 55 oxidative metabolism 55 ketorolac 55 bypass grafting 55 cranial irradiation 55 vessel occlusion 55 BEXXAR Therapeutic Regimen 55 torsade de pointes 55 parathyroidectomy 55 TNF antagonist 55 CsA 55 taxane therapy 55 HCV replication 55 micrometastasis 55 leukotriene pathway 55 Pseudomonas aeruginosa infections 55 paclitaxel Taxol 55 VeriStrat 55 postoperative complication 55 mitochondrial fusion 55 methacholine challenge 55 motor neuron degeneration 55 Aβ 55 glucocorticoid receptor 55 neovascularization 55 apoptotic pathway 55 Th2 cytokines 55 blood Phe levels 55 coronary vasodilation 55 eicosanoids 55 endothelial cell